Patent Assignment
Reel/Frame 026606/0061
Security Agreement
Recorded: 2011-07-18
Received: 2011-07-18
Pages: 19
Assignors
ATON PHARMA, INC., A DELAWARE CORPORATION
Executed: 2011-06-29
CORIA LABORATORIES, LTD., A DELAWARE CORPORATION
Executed: 2011-06-29
DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
Executed: 2011-06-29
PRESTWICK PHARMACEUTICALS, INC., A DELAWARE CORPORATION
Executed: 2011-06-29
VALEANT BIOMEDICALS, INC., A DELAWARE CORPORATION
Executed: 2011-06-29
VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION
Executed: 2011-06-29
VALEANT PHARMACEUTICALS NORTH AMERICA LLC, A DELAWARE LLC
Executed: 2011-06-29
Assignee
GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
200 WEST STREET, NEW YORK, NY, 10282, UNITED STATES
Covered Properties
(70)
Pyridone Sulfonamides and Pyridone Sulfamides as Mek Inhibitors
Application:
13/009,052 →
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Application:
12/928,306 →
Stereoselective Synthesis of Metyrosine
Application:
12/916,318 →
Ocular Drug Delivery Devices
Application:
12/916,398 →
PCT:
PCTUS2010054823 ↗
Suspension Containing Micronized Benzoyl Peroxide
Application:
12/925,214 →
Ocular Drug Delivery Devices
Application:
61/391,040 →
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Application:
12/876,997 →
Combinations of Retigabine and Sodium Channel Inhibitors or Sodium Channel-Influencing Active Compounds for Treating Pains
Application:
12/871,860 →
Derivatives of 5-Amino-4,6-Disubstituted Indole and 5-Amino-4,6-Disubstituted Indoline as Potassium Channel Modulators
Application:
12/856,514 →
Compositions and Methods for Treating Diseases of the Nail
Application:
12/803,848 →
Azithromycin for the treatment of nodular acne
Application:
12/799,401 →
N-(4-(6-Fluoro-3,4-Dihydroisoquinolin-2(1H)-Yl)-2,6-Dimethylphenyl)-3,3-Dimethylbutanamide as Potassium Channel Modulators
Application:
12/698,070 →
Modified Release Formulation and Methods of Use
Application:
12/691,680 →
Modified Release Formulation and Methods of Use
Application:
12/690,889 →
Aqueous compositions containing metronidazole
Application:
12/589,680 →
Method for obtaining a stable dispersion of benzoyl peroxide
Application:
12/589,236 →
Modified Release Formulation and Methods of Use
Application:
12/505,409 →
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Application:
12/491,055 →
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Application:
12/455,525 →
Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders
Application:
12/382,511 →
Derivatives of N-(Arylamino) Sulfonamides as Inhibitors of Mek
Application:
12/323,279 →
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Application:
12/242,681 →
Azithromycin for Treatment of Skin Disorders
Application:
12/231,586 →
Derivatives of 5-Amino-4,6-Disubstituted Indole and 5-Amino-4,6-Disubstituted Indoline as Potassium Channel Modulators
Application:
12/189,709 →
Naphthyridine Derivatives as Potassium Channel Modulators
Application:
12/181,126 →
Uses of Trientine and Penicillamine as Countermeasures to Metal Contamination
Application:
12/180,130 →
3-Hydroxyisothiazole-4-Carboxamidine Derivatives as CHK2 Inhibitors
Application:
12/143,672 →
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Application:
12/138,251 →
Method for increasing the solubility of betacyclodextrin
Application:
12/072,578 →
Method for Stabilizing Polypeptides Lacking Methionine
Application:
12/069,745 →
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Application:
12/012,413 →
Compositions and methods for treating diseases of the nail
Application:
12/006,531 →
Controlled Release Azithromycin Solid Dosages Forms
Application:
12/002,417 →
1,4 Diamino Bicyclic Retigabine Analogues as Potassium Channel Modulators
Application:
11/946,822 →
N-[2-Amino-4-(Phenylmethoxy)Phenyl] Amides and Related Compounds as Potassium Channel Modulators
Application:
11/870,368 →
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Application:
11/894,877 →
Derivatives of 1,3-diamino benzene as potassium channel modulators
Application:
11/893,724 →
Derivatives of N-(Arylamino) Sulfonamides as Inhibitors of Mek
Application:
11/830,733 →
Topical Acne Vulgaris Medication with a Sunscreen
Application:
11/823,385 →
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Application:
11/810,114 →
Pyridone Sulfonamides and Pyridone Sulfamides as Mek Inhibitors
Application:
11/737,109 →
N-Aryl-N'alkyl Sulfamides as Mek Inhibitors
Application:
11/734,234 →
Two-phase mucoadhesive composition
Application:
11/654,921 →
Azithromycin for the Treatment of Nodular Acne
Application:
11/635,127 →
Alpha Hydroxy Acid Sustained Release Formulation
Application:
11/490,896 →
Use of a clobetasol spray formulation to treat psoriasis
Application:
11/408,105 →
Topical Acne Vulgairs Medication with a Sunscreen
Application:
11/393,981 →
2-Beta-Modified-6-Substituted Adenosine Analogs and Their Use as Antiviral Agents
Application:
10/530,627 →
Novel Heterocyclic Compounds Having Anti-Hbv Activity
Application:
11/347,145 →
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Application:
10/542,235 →
Piperidin-2,6-Dione Pamoate Salts and Their Use for the Treatment of Stress-Related Affective Disorders
Application:
10/524,693 →
Derivatives of Glycinergic R(+)-2-Amino-3-Hydroxypropanoic Acid
Application:
10/524,869 →
Aqueous Compositions Containing Metronidazole
Application:
11/037,430 →
Quinoxaline Derivatives Having Antiviral Activity
Application:
10/826,439 →
Novel Piperidin-2,6-Dione Bisulphate Salts and Their Use for the Treatment of Stress Related Affective Disorders
Application:
10/486,925 →
Combinations of Retigabine and Sodium Channel Inhibitors or Sodium Channel-Influencing Active Compounds for Treating Pains
Application:
10/727,655 →
Use of Ribofuranose Derivatives Against Inflammatory Bowel Diseases
Application:
10/618,148 →
Heterocyclic Compounds and Uses Thereof
Application:
10/455,149 →
Antiviral Phosphonate Compounds and Methods Therefor
Application:
10/426,507 →
Drug Delivery System for Administering an Adjustable Preset Dose
Application:
10/367,626 →
Nucleoside Compounds and Uses Thereof
Application:
10/318,476 →
Nucleoside Analogs with Carboxamidine Modified Monocyclic Base
Application:
10/227,235 →
Monocyclic L-Nucleosides, Analogs and Uses Thereof
Application:
10/120,101 →
Tirazole Nucleoside Analogs and Methods for Using Same
Application:
10/095,665 →
Skin Cream
Application:
10/094,534 →
Topical Gel Delivery System
Application:
10/096,516 →
Monocyclic L-Nucleosides, Analogs and Uses Thereof
Application:
09/969,355 →
Aqueous Compositions Containing Metronidazole
Application:
10/033,835 →
Skin Cleanser Comprising a Steareth, Poloxamer and a Glyceryl Monoester
Application:
09/802,047 →
Treatment of hcv with subtherapeutic doses of ribavirin
Application:
11/919,268 →